87 related articles for article (PubMed ID: 17028221)
21. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
[TBL] [Abstract][Full Text] [Related]
22. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
23. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
24. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
25. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
[TBL] [Abstract][Full Text] [Related]
26. Persistence of cell-mediated immunity to vaccinia virus.
Kim SH; Oh MD
J Infect Dis; 2007 Sep; 196(5):805-6. PubMed ID: 17674329
[No Abstract] [Full Text] [Related]
27. Progressive vaccinia associated with combined variable immunodeficiency.
Keane JT; James K; Blankenship ML; Pearson RW
Arch Dermatol; 1983 May; 119(5):404-8. PubMed ID: 6847220
[TBL] [Abstract][Full Text] [Related]
28. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
Kitano S; Kageyama S; Nagata Y; Miyahara Y; Hiasa A; Naota H; Okumura S; Imai H; Shiraishi T; Masuya M; Nishikawa M; Sunamoto J; Akiyoshi K; Kanematsu T; Scott AM; Murphy R; Hoffman EW; Old LJ; Shiku H
Clin Cancer Res; 2006 Dec; 12(24):7397-405. PubMed ID: 17189412
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
30. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
Ferrier-Rembert A; Drillien R; Meignier B; Garin D; Crance JM
Vaccine; 2007 Nov; 25(49):8290-7. PubMed ID: 17964011
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship.
Ovsyannikova IG; Haralambieva IH; Kennedy RB; O'Byrne MM; Pankratz VS; Poland GA
J Infect Dis; 2013 Nov; 208(9):1422-30. PubMed ID: 23901078
[TBL] [Abstract][Full Text] [Related]
32. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Miller JD; van der Most RG; Akondy RS; Glidewell JT; Albott S; Masopust D; Murali-Krishna K; Mahar PL; Edupuganti S; Lalor S; Germon S; Del Rio C; Mulligan MJ; Staprans SI; Altman JD; Feinberg MB; Ahmed R
Immunity; 2008 May; 28(5):710-22. PubMed ID: 18468462
[TBL] [Abstract][Full Text] [Related]
33. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
34. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
35. The immunogenetics of smallpox vaccination.
Stanley SL; Frey SE; Taillon-Miller P; Guo J; Miller RD; Koboldt DC; Elashoff M; Christensen R; Saccone NL; Belshe RB
J Infect Dis; 2007 Jul; 196(2):212-9. PubMed ID: 17570108
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
37. The lipophilic hapten parthenolide induces interferon-gamma and interleukin-13 production by peripheral blood-derived CD8+ T cells from contact allergic subjects in vitro.
Wahlkvist H; Masjedi K; Gruvberger B; Zuber B; Karlberg AT; Bruze M; Ahlborg N
Br J Dermatol; 2008 Jan; 158(1):70-7. PubMed ID: 17986299
[TBL] [Abstract][Full Text] [Related]
38. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
[TBL] [Abstract][Full Text] [Related]
39. Detection of human papillomavirus type 16-specific T lymphocytes by a recombinant vaccinia virus-based enzyme-linked immunospot assay.
Kim KH; Greenfield W; Shotts E; Nakagawa M
Clin Vaccine Immunol; 2007 Apr; 14(4):362-8. PubMed ID: 17314231
[TBL] [Abstract][Full Text] [Related]
40. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses.
Couch RB; Winokur P; Edwards KM; Black S; Atmar RL; Stapleton JT; Kissner JM; Shinefield H; Denny TN; Bybel MJ; Newman FK; Yan L;
J Infect Dis; 2007 Mar; 195(6):826-32. PubMed ID: 17299712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
